Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Dijiao Tang, Yuetong Guo, Yi Tang & Hongxu Wang. (2022) Treatment and Outcome of Castleman Disease: A Retrospective Report of 31 Patients. Therapeutics and Clinical Risk Management 18, pages 499-509.
Read now
Read now
Dan Yang, Xuan Zhou, Youcai Zhao, Shibin Cao, Ailing Su, Xuezhong Zhang, Yanli Xu & Xiuqun Zhang. (2018) A rare case of multicentric castleman's disease transforms into multiple myeloma and its successful treatment. Cancer Biology & Therapy 19:11, pages 949-952.
Read now
Read now
Andrea Ferrario, Michele Merli, Claudia Basilico, Margherita Maffioli & Francesco Passamonti. (2017) Siltuximab and hematologic malignancies. A focus in non Hodgkin lymphoma. Expert Opinion on Investigational Drugs 26:3, pages 367-373.
Read now
Read now
Kah-Lok Chan, Stephen Lade, H Miles Prince & Simon J Harrison. (2016) Update and new approaches in the treatment of Castleman disease. Journal of Blood Medicine 7, pages 145-158.
Read now
Read now
Articles from other publishers (85)
Imen Chabchoub, Raida Ben Salah, Rim Kallel, Mouna Snoussi, Feten Frikha, Sameh Marzouk, Tahya Sellami Boudawara & Zouhir Bahloul. (2023) Clinical features and outcomes in patients with human immunodeficiency virus-negative, Castleman disease: a single medical center study in Tunisia. Romanian Journal of Internal Medicine 0:0.
Crossref
Crossref
Ashwini Gupta, Ayush Anand, Salman Haidar Hussain, Raju Shah, Rajesh Ranjan, Viplaw Subedi, Aastha Baral, Akshat Mishra, Anju Pradhan & Soniya Dulal. (2023)
Transformation of
HHV
‐8‐negative idiopathic multicentric Castleman disease into diffuse large
B‐cell
lymphoma: A case report from Nepal
. Clinical Case Reports 11:9.
Crossref
Crossref
Santosh Dev, Kailash Mani Pokhrel, Pashupati Pokharel, Ramesh Singh Bhandari & Sumita Pradhan. (2023) Castleman disease of the pancreas mimicking pancreatic neuroendocrine tumor: A rare case report. International Journal of Surgery Case Reports 109, pages 108524.
Crossref
Crossref
Eman Mosleh, Sarah Mehta, Erika Young, Lily Zhang, Kiran Vij & Laura G. Schuettpelz. (2023) Idiopathic multicentric Castleman disease in an adolescent diagnosed following COVID‐19 infection. Pediatric Blood & Cancer 70:6.
Crossref
Crossref
Bai Zhou, Chao Tang, Guiyang Chen, Tiebin Jiang, Xiao Shi & Fen Wang. (2022) TAFRO syndrome with fatigue and abdominal distension as the first symptom: A case report. Hematological Oncology 41:2, pages 285-290.
Crossref
Crossref
Xiaoxin Shi, Mengying Liao, Xiaomin Yin, Yaoli Chen, Chuqiang Huang, Weihua Yin & Jian Li. (2023) Case report: The stroma-rich variant of Castleman’s disease of hyaline-vascular type with atypical stromal cell proliferation and malignant potential: An exceptional rare case occurred in mediastinal lymph node. Frontiers in Oncology 13.
Crossref
Crossref
Jiri Molacek, Vladislav Treska, Tomas Skalicky, Josef Vodicka, Jiri Ferda, Eva Ferdova, Jan Baxa, Christiana Mach, Alexandra Jungova & Michael Michal. (2023) Unicentric form of Castleman´s disease, pitfalls of diagnosis and surgical treatment. Frontiers in Oncology 13.
Crossref
Crossref
Kaori Sonoda, Utako Kaneko, Makoto Hiura, Yoshiaki Kinoshita, Hajime Umezu, Shuichi Ito, Akihiko Saitoh & Chihaya Imai. (2023) Short stature as an initial presenting presentation of unicentric Castleman disease in a child: A case report with long-term follow-up and a literature review. Modern Rheumatology Case Reports 7:1, pages 261-266.
Crossref
Crossref
Li He, Yu Chen, Xiaoyue Tan, Xiaolin Sun, Qing Zhang, Haiying Luo & Lei Jiang. (2022) 18F-FDG PET/CT and contrast-enhanced CT in the diagnosis of Castleman disease. Japanese Journal of Radiology 41:1, pages 98-107.
Crossref
Crossref
Nadezda Buntic, Taylor Brown, Ummah Salma Nisar & Christopher Yeary. (2022) Unicentric Castleman’s Disease Presenting As Back Pain. Cureus.
Crossref
Crossref
R. Bertinchamp & L. Terriou. (2022) Maladies de Castleman : épidémiologie, classification et critères diagnostiques. La Revue de Médecine Interne 43:10, pages 10S4-10S9.
Crossref
Crossref
Natalia Georgantzoglou, Michael Baker, Xiaoying Liu, Darcy A. Kerr & Konstantinos Linos. (2022) Castleman Disease with MDM2/CDK4 Protein Expression: a Potential Mimic of Inflammatory Variant of Liposarcoma with Significant Consequences. International Journal of Surgical Pathology 30:7, pages 753-759.
Crossref
Crossref
Michael Krokenberger, Kristina Schwamborn & Ulrich Strassen. (2022)
Prevalence of
Castleman's
disease in patients suffering from cervical lymphadenopathy
. Laryngoscope Investigative Otolaryngology 7:5, pages 1430-1435.
Crossref
Crossref
Christopher M. Janson, Marisa E. Millenson, Oluwatimilehin Okunowo, Dingwei Dai, Zane Christmyer, Reina Bianca Tan, V. Ramesh Iyer, Maully J. Shah & Michael L. O’Byrne. (2022) Incidence of life-threatening events in children with Wolff-Parkinson-White syndrome: Analysis of a large claims database. Heart Rhythm 19:4, pages 642-647.
Crossref
Crossref
Zdeněk Adam, Zdeněk Řehák, Zuzana Adamová, Renata Koukalová, Luděk Pour, Marta Krejčí, Ivanna Boichuk, Viera Sandecká, Martin Krejčí, Martin Štork, Sabina Ševčíková & Zdeněk Král. (2022) Multicentric Castleman's disease. Symptoms, diagnostics and therapy. Vnitřní lékařství 68:1, pages 41-53.
Crossref
Crossref
Daniel Ion, Alexandra Bolocan, Alexandru Filipescu, Octavian Andronic, Ana-Maria Oproiu, Adelina Popa & Dan Păduraru. (2022) A mesorectal incidentaloma: Rare localization of Castleman disease (Case report). Experimental and Therapeutic Medicine 23:4.
Crossref
Crossref
Sudipto MukherjeeRabecka Martin, Brenda Sande, Jeremy S. Paige & David C. Fajgenbaum. (2022) Epidemiology and treatment patterns of idiopathic multicentric Castleman disease in the era of IL-6–directed therapy. Blood Advances 6:2, pages 359-367.
Crossref
Crossref
Bingqing Yue, Jian Huang, Lei Jing, Huaqing Yu, Dong Wei, Ji Zhang, Wenhui Chen & Jingyu Chen. (2021) Bilateral lung transplantation for Castleman disease with end‐stage bronchiolitis obliterans. Clinical Transplantation 36:1.
Crossref
Crossref
Hajime Kaga, Honami Kurahashi, Arisa Kubota, Yoshiaki Hatano, Hiroshi Nanjo, Hideki Wakui & Naoto Takahashi. (2021) Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease. International Journal of Hematology 115:1, pages 129-134.
Crossref
Crossref
Zdeněk Adam, Zdeněk Řehák, Zuzana Adamová, Renata Koukalová, Luděk Pour, Marta Krejčí, Ivanna Boichuk, Martin Krejčí, Martin Štork, Sabina Ševčíková & Zdeněk Král. (2021) Unicentric Castleman's disease. Symptoms, diagnostics and therapy. Vnitřní lékařství 67:8, pages 465-473.
Crossref
Crossref
Bolong Liu, Yong Huang, Luying Tang, Jiexia Guan, Xiangfu Zhou & Hailun Zhan. (2021) Inflammatory pseudotumor of Castleman disease and IgG4-related disease masquerading as kidney malignancy. Diagnostic Pathology 16:1.
Crossref
Crossref
XiuLi Zhu, Si Chen, Fang Fang, Yong Jia & KaiGuang Zhang. (2021) An unusual cause of ascites: Castleman disease. BMC Gastroenterology 21:1.
Crossref
Crossref
Natalia A. Zapata-Salazar, Minerva Gómez-Flores, Jorge Ocampo-Candiani & Sonia Chavez-Alvarez. (2021) Cutaneous Manifestations of Castleman Disease: Histopathological Characteristics and Review of Literature. The American Journal of Dermatopathology 43:12, pages 926-931.
Crossref
Crossref
Antonino Carbone, Margaret Borok, Blossom Damania, Annunziata Gloghini, Mark N. Polizzotto, Raj K. Jayanthan, David C. Fajgenbaum & Mark Bower. (2021) Castleman disease. Nature Reviews Disease Primers 7:1.
Crossref
Crossref
Oliver C. Lomas, Matthew Streetly, Guy Pratt, Jim Cavet, Daniel Royston, Stephen Schey & Karthik Ramasamy. (2021) The management of Castleman disease. British Journal of Haematology 195:3, pages 328-337.
Crossref
Crossref
Sheila K. Pierson, Sushila ShenoyAna B. OromendiaAlexander M. GorzewskiRuth-Anne Langan PaiChristopher Shield NabelJason R. RuthSophia A. T. Parente, Daniel J. ArenasMary GuilfoyleManjula ReddyMichael WeinblattNancy Shadick, Mark Bower, Alessia Dalla PriaYasufumi MasakiLaura KatzJason MezeyPhilip BeinekeDavid LeeCraig TendlerTaku KambayashiAlexander FossåFrits van Rhee & David C. Fajgenbaum. (2021) Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease. Blood Advances 5:17, pages 3445-3456.
Crossref
Crossref
Rashpal Singh, Rizul Prasher, Shivek Mohan & Bharat Thakur. (2021) Retroperitoneal unicentric Castleman's disease—A case report and review of literature. International Journal of Surgery Case Reports 86, pages 106325.
Crossref
Crossref
Lama Kadoura, Amr Hamza, Afnan W M Jobran, Yousef Mahmoud Nimer Habes, Sarab Agha, Rama Alyousfi & Kusay Ayoub. (2021) Unicentric Castleman disease in the mesentery with ambiguous symptoms: a rare case report. Journal of Surgical Case Reports 2021:8.
Crossref
Crossref
Ying Yin, Ting Yu & Sachin Mulmi Shrestha. (2021) Unicentric Castleman’s disease of hepatic hilum and retroperitoneum: a case report for endoscopic ultrasonography differential diagnosis and a literature review. Clinical Journal of Gastroenterology 14:4, pages 1250-1254.
Crossref
Crossref
Deepika Gunda, Jack Naughton, Sean Gregory Stevens & Marcos V Perini. (2021) Castleman’s disease masquerading as pancreatic neuroendocrine tumour. BMJ Case Reports 14:6, pages e242597.
Crossref
Crossref
C. Hoffmann, J. Tepel & M. Tiemann. (2021) Morbus Castleman – ein seltenes, heterogenes KrankheitsbildCastleman disease—a rare, heterogeneous syndrome. best practice onkologie 16:5, pages 198-206.
Crossref
Crossref
Benjamin Koa, Austin J. Borja, Mahmoud Aly, Sayuri Padmanabhan, Joseph Tran, Vincent Zhang, Chaitanya Rojulpote, Sheila K. Pierson, Mark-Avery Tamakloe, Johnson S. Khor, Thomas J. Werner, David C. Fajgenbaum, Abass Alavi & Mona-Elisabeth Revheim. (2021) Emerging role of 18F-FDG PET/CT in Castleman disease: a review. Insights into Imaging 12:1.
Crossref
Crossref
Kalliopi Azariadis, Maria Ioannou, Kalliopi Zachou & George N. Dalekos. (2021) An Immunocompetent HIV-Negative Elderly Patient with Low-Grade Fever, Generalized Lymphadenopathy, Splenomegaly, and Acute Phase Response: Do Not Forget Castleman Disease. Case Reports in Infectious Diseases 2021, pages 1-7.
Crossref
Crossref
Ya-Ju Wu & Kuei-Ying Su. (2021) Updates on the diagnosis and management of multicentric Castleman disease. Tzu Chi Medical Journal 33:1, pages 22.
Crossref
Crossref
Soo Jie Chung, Kyung‐Min Ahn, Ji Hyun Oh, Ji‐Su Shim & Heung‐Woo Park. (2020) Incidence rates of severe cutaneous adverse reactions due to antiseizure medication: A nationwide study using health claims data in Korea. Epilepsia 62:1, pages 250-257.
Crossref
Crossref
Theerajet Guayboon, Yingyong Chinthammitr, Sanya Sukpanichnant, Navin Horthongkham & Nasikarn Angkasekwinai. (2021) Human herpesvirus 8-associated multicentric Castleman disease in a patient with advanced HIV infection. Medicine 100:49, pages e28077.
Crossref
Crossref
Xiaosheng Fang, Zhongling Sun, Zijun Y. Xu-Monette & Ken H. Young. (2021) Predictive Model for Idiopathic Multicentric Castleman Disease Supporting Treatment Decisions. The Oncologist 26:1, pages 4-6.
Crossref
Crossref
Frits van Rhee, Eric Oksenhendler, Gordan SrkalovicPeter VoorheesMegan LimAngela Dispenzieri, Makoto IdeSophia ParenteStephen ScheyMatthew StreetlyRaymond WongDavid WuIvan MaillardJoshua BrandstadterNikhil MunshiWilbur BowneKojo S. Elenitoba-JohnsonAlexander FössaMary Jo LechowiczShanmuganathan ChandrakasanSheila K. PiersonAmy GreenwaySunita NastaKazuyuki YoshizakiRazelle Kurzrock, Thomas S. UldrickCorey Casper, Amy Chadburn & David C. Fajgenbaum. (2020) International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Advances 4:23, pages 6039-6050.
Crossref
Crossref
Yuejuan Pan, Zhuan Cui, Song Wang, Danxia Zheng, Zhenling Deng, Xinyu Tian, Hongxia Guo, Wenhan Bao, Sijia Zhou & Yue Wang. (2020) Idiopathic multicentric Castleman disease with Sjögren’s syndrome and secondary membranous nephropathy: a case report and review of the literature. BMC Nephrology 21:1.
Crossref
Crossref
Sheila K. Pierson, Johnson S. Khor, Jasira Ziglar, Amy Liu, Katherine Floess, Erin NaPier, Alexander M. Gorzewski, Mark-Avery Tamakloe, Victoria Powers, Faizaan Akhter, Eric Haljasmaa, Raj Jayanthan, Arthur Rubenstein, Mileva Repasky, Kojo Elenitoba-Johnson, Jason Ruth, Bette Jacobs, Matthew Streetly, Linus Angenendt, Jose Luis Patier, Simone Ferrero, Pier Luigi Zinzani, Louis Terriou, Corey Casper, Elaine Jaffe, Christian Hoffmann, Eric Oksenhendler, Alexander Fosså, Gordan Srkalovic, Amy Chadburn, Thomas S. Uldrick, Megan Lim, Frits van Rhee & David C. Fajgenbaum. (2020) ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder. Cell Reports Medicine 1:9, pages 100158.
Crossref
Crossref
Eun Ji Han, Joo Hyun O, Seung-Eun Jung, Gyeongsin Park, Byung-Ock Choi, Young-Woo Jeon, Gi-June Min & Seok-Goo Cho. (2020) FDG PET/CT Findings of Castleman Disease Assessed by Histologic Subtypes and Compared with Laboratory Findings. Diagnostics 10:12, pages 998.
Crossref
Crossref
Isabel Hodl, Philipp Bosch, Barbara Dreo & Martin H. Stradner. (2020) Case Report: Extensive Phosphorylation of Interleukin-1 Receptor-Associated Kinase 4 in a Patient With Schnitzler Syndrome. Frontiers in Immunology 11.
Crossref
Crossref
Kirill A. Lyapichev, M. James You, Francisco Vega, Luisa M. Solis & L. Jeffrey Medeiros. (2020) Classic Hodgkin lymphoma and Castleman disease: an entity appears to be emerging. Virchows Archiv 477:3, pages 437-444.
Crossref
Crossref
Ruth-Anne Langan Pai, Alberto Sada Japp, Michael Gonzalez, Rozena F. Rasheed, Mariko Okumura, Daniel Arenas, Sheila K. Pierson, Victoria Powers, Awo Akosua Kesewa Layman, Charlly Kao, Hakon Hakonarson, Frits van Rhee, Michael R. Betts, Taku Kambayashi & David C. Fajgenbaum. (2020) Type I IFN response associated with mTOR activation in the TAFRO subtype of idiopathic multicentric Castleman disease. JCI Insight 5:9.
Crossref
Crossref
Danielle Reny, Sharvari Dalal, Darshana Jhala & Natasha Mirza. (2020) Unicentric Castleman disease and lymphoepithelial cyst of the parotid: A case report and review of the literature. Oral Science International 17:2, pages 106-110.
Crossref
Crossref
Angela Dispenzieri & David C. Fajgenbaum. (2020) Overview of Castleman disease. Blood 135:16, pages 1353-1364.
Crossref
Crossref
Manuel Toscano, Sergio Cristina, Patricia Cipriano & Ana Rafaela Alves. (2020) Misdiagnosing multicentric Castleman’s disease in an HIV-positive patient. Revista da Associação Médica Brasileira 66:4, pages 401-404.
Crossref
Crossref
You-Xin Zhou, Yong Ji & Sheng Wu. (2020) A CARE-compliant article: Unicentric Castleman disease presenting as a retroperitoneal mass of the upper edge of the pancreas. Medicine 99:11, pages e19515.
Crossref
Crossref
Shuyan Liu, Yuanwen Wang, Tonglin Hu, Chunli ZhangZhiyin Zheng. (2020) Peripheral T cell lymphoma coexisting with Castleman's disease. Medicine 99:2, pages e18650.
Crossref
Crossref
Ben Ismail Imen, Hakim Zenaidi, Yahmadi Abdelwahed, Rebii Sabeur & Zoghlami Ayoub. (2020) Management of isolated retroperitoneal Castelman’s disease: A case report. International Journal of Surgery Case Reports 70, pages 24-27.
Crossref
Crossref
John M. Astle, Megan S. Lim & Kojo S. Elenitoba-Johnson. 2020. Hematopathology. Hematopathology
99
105
.
Alexander Suarez, Curran Reilly & David C. Fajgenbaum. (2019) Quantitative analysis of a rare disease network’s international contact database and E-repository provides insights into biobanking in the electronic consent era. Orphanet Journal of Rare Diseases 14:1.
Crossref
Crossref
Zi Ying Li, Shirley Kim, SiYi Huang & Raza Mian. (2019) Multicentric Castleman disease with TAFRO syndrome and Sjögren's. Clinical Case Reports 7:12, pages 2388-2392.
Crossref
Crossref
Christian Hoffmann & Markus Tiemann. (2019) Multizentrischer Morbus Castleman: Selten korrekt diagnostiziert. Deutsches Ärzteblatt Online.
Crossref
Crossref
David C. Fajgenbaum, Ruth-Anne Langan, Alberto Sada Japp, Helen L. Partridge, Sheila K. Pierson, Amrit Singh, Daniel J. Arenas, Jason R. Ruth, Christopher S. Nabel, Katie Stone, Mariko Okumura, Anthony Schwarer, Fábio Freire Jose, Nelson Hamerschlak, Gerald B. Wertheim, Michael B. Jordan, Adam D. Cohen, Vera Krymskaya, Arthur Rubenstein, Michael R. Betts, Taku Kambayashi, Frits van Rhee & Thomas S. Uldrick. (2019) Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease. Journal of Clinical Investigation 129:10, pages 4451-4463.
Crossref
Crossref
Jenna Sopfe, Ashley Endres, Kristen Campbell, Kari Hayes, Andrew T. Trout, Xiayuan Liang, Robert Lorsbach, Maureen M. O'Brien & Carrye R. Cost. (2019) Castleman disease in pediatrics: Insights on presentation, treatment, and outcomes from a two‐site retrospective cohort study. Pediatric Blood & Cancer 66:5.
Crossref
Crossref
Guanyu Yu, Fuao Cao, Haifeng Gong, Peng Liu, Ge Sun & Wei Zhang. (2019) Embolization of blood-supply artery followed by surgery for treatment of mesorectal Castleman’s disease: case report and literature review. Gastroenterology Report 7:2, pages 141-145.
Crossref
Crossref
Bo Zhai, Hai-Yang Ren, Wei-Dong Li, Shiva Reddy, Shu-Jun Zhang & Xue-Ying Sun. (2019) Castleman disease presenting with jaundice: A case report and review of literature. World Journal of Clinical Cases 7:3, pages 373-381.
Crossref
Crossref
Yasufumi Masaki, Hiroshi Kawabata, Shino Fujimoto, Mitsuhiro Kawano, Noriko Iwaki, Takeharu Kotani, Akikatsu Nakashima, Nozomu Kurose, Kazue Takai, Ritsuro Suzuki & Sadao Aoki. (2019) Epidemiological analysis of multicentric and unicentric Castleman disease and TAFRO syndrome in Japan. Journal of Clinical and Experimental Hematopathology 59:4, pages 175-178.
Crossref
Crossref
David Leo Choi, Kristina Brannock & Alice L Tang. (2019) Castleman Disease Presenting as a Parapharyngeal Mass: A Case Report and Review of the Literature. Clinical Medicine Insights: Case Reports 12, pages 117954761985379.
Crossref
Crossref
Ricky H. Bhogal, Andrew Wotherspoon & Aamir K. Khan. (2019) Mesenteric Castleman’s disease mimicking neuroendocrine tumour. International Journal of Surgery Case Reports 63, pages 56-58.
Crossref
Crossref
Yi Dong, Bing Liu, Guanqun Ju, Jiao Cai, Nan Zhang & Lin-hui Wang. (2019) Concomitant perinephric Castleman disease and renal cell carcinoma initially suspected to be metastasis: A case report and 24 months follow up. Urology Case Reports 22, pages 70-72.
Crossref
Crossref
Chase H. Foster, Cyrus Elahi, Stephen Cheney, Todd Trier, Alireza Torabi & Niti Manglik. (2018) Thoracic Paraspinal Castleman Disease in a Young Mexican-American Man with Postcoital Hematuria. World Neurosurgery 120, pages 36-42.
Crossref
Crossref
David C. Fajgenbaum. (2018) Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Hematology 2018:1, pages 318-325.
Crossref
Crossref
David C. Fajgenbaum. (2018) Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Blood 132:22, pages 2323-2330.
Crossref
Crossref
Jia-Lin Cheng, Jing Cui, Yi Wang, Zong-Zhen Xu, Feng Liu, Shu-Bin Liang & Hu Tian. (2018) Unicentric Castleman disease presenting as a retroperitoneal peripancreatic mass: A report of two cases and review of literature. World Journal of Gastroenterology 24:34, pages 3958-3964.
Crossref
Crossref
Semra Paydas. (2018) Tafro syndrome: Critical review for clinicians and pathologists. Critical Reviews in Oncology/Hematology 128, pages 88-95.
Crossref
Crossref
Jhen-Hao Jhan, Ching-Chia Li, Wen-Jeng Wu & Hsiang-Ying Lee. (2018) Isolated retroperitoneal Castleman's disease: A case report and literature review. Clinical Case Reports 6:8, pages 1543-1548.
Crossref
Crossref
Samantha J. Wala, Erica M. Fallon, Christopher J. Forlenza, Neerav Shukla & Michael P. LaQuaglia. (2018) Unicentric Castleman disease in the mediastinum. Journal of Pediatric Surgery Case Reports 34, pages 51-53.
Crossref
Crossref
Sheila K. Pierson, Aaron J. Stonestrom, Dustin Shilling, Jason Ruth, Christopher S. Nabel, Amrit Singh, Yue Ren, Katie Stone, Hongzhe Li, Frits van Rhee & David C. Fajgenbaum. (2018) Plasma proteomics identifies a ‘chemokine storm’ in idiopathic multicentric Castleman disease. American Journal of Hematology 93:7, pages 902-912.
Crossref
Crossref
Raymond S.M. Wong. (2018) Unicentric Castleman Disease. Hematology/Oncology Clinics of North America 32:1, pages 65-73.
Crossref
Crossref
David Wu, Megan S. Lim & Elaine S. Jaffe. (2018) Pathology of Castleman Disease. Hematology/Oncology Clinics of North America 32:1, pages 37-52.
Crossref
Crossref
David Simpson. (2018) Epidemiology of Castleman Disease. Hematology/Oncology Clinics of North America 32:1, pages 1-10.
Crossref
Crossref
John M. Astle, Megan S. Lim & Kojo S. Elenitoba-Johnson. 2018. Encyclopedia of Pathology. Encyclopedia of Pathology
1
7
.
Umberto Bracale, Francesco Pacelli, Marco Milone, Umberto Marcello Bracale, Maurizio Sodo, Giovanni Merola, Teresa Troiani & Enrico Di Salvo. (2017) Laparoscopic treatment of abdominal unicentric castleman’s disease: a case report and literature review. BMC Surgery 17:1.
Crossref
Crossref
David Fajgenbaum. (2017) Leveraging information and collaboration to cure disease. Information Services & Use 37:3, pages 307-311.
Crossref
Crossref
Jennifer DeCotiis & David Lukac. (2017) KSHV and the Role of Notch Receptor Dysregulation in Disease Progression. Pathogens 6:3, pages 34.
Crossref
Crossref
Wan Cheol Ryu, Moon Hyang Park, Hoon Kim, In Chang Koh & Kyu Nam Kim. (2017) Rare Location of Castleman&'s Disease in the Temporal Region: A Case Report Involving a Young Korean Woman and Review of the Literature. Archives of Craniofacial Surgery 18:2, pages 122-127.
Crossref
Crossref
David A. Johnson, David Lieberman, John M. Inadomi, Uri Ladabaum, Richard C. Becker, Seth A. Gross, Kristin L. Hood, Susan Kushins, Mark Pochapin & Douglas J. Robertson. (2017) Increased Post-procedural Non-gastrointestinal Adverse Events After Outpatient Colonoscopy in High-risk Patients. Clinical Gastroenterology and Hepatology 15:6, pages 883-891.e9.
Crossref
Crossref
Li YuMeifeng TuJorge Cortes, Zijun Y. Xu-MonetteRoberto N. MirandaJun ZhangRobert Z. OrlowskiSattva NeelapuPrajwal C. Boddu, Mary A. Akosile, Thomas S. UldrickRobert YarchoanL. Jeffrey MedeirosYong LiDavid C. Fajgenbaum & Ken H. Young. (2017) Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease. Blood 129:12, pages 1658-1668.
Crossref
Crossref
David C. FajgenbaumThomas S. UldrickAdam BaggDale FrankDavid WuGordan SrkalovicDavid SimpsonAmy Y. LiuDavid MenkeShanmuganathan ChandrakasanMary Jo LechowiczRaymond S. M. Wong, Sheila PiersonMichele PaesslerJean-François RossiMakoto IdeJason RuthMichael CroglioAlexander SuarezVera KrymskayaAmy ChadburnGisele ColleoniSunita NastaRaj JayanthanChristopher S. NabelCorey CasperAngela DispenzieriAlexander FossåDermot KelleherRazelle KurzrockPeter VoorheesAhmet DoganKazuyuki YoshizakiFrits van Rhee, Eric Oksenhendler, Elaine S. JaffeKojo S. J. Elenitoba-JohnsonMegan S. Lim. (2017) International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease. Blood 129:12, pages 1646-1657.
Crossref
Crossref
Shayna Sarosiek, Ruchit Shah & Nikhil C. Munshi. (2016) Review of siltuximab in the treatment of multicentric Castleman’s disease. Therapeutic Advances in Hematology 7:6, pages 360-366.
Crossref
Crossref
David C Fajgenbaum, Jason R Ruth, Dermot Kelleher & Arthur H Rubenstein. (2016) The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease research. The Lancet Haematology 3:4, pages e150-e152.
Crossref
Crossref
Amy Y Liu, Christopher S Nabel, Brian S Finkelman, Jason R Ruth, Razelle Kurzrock, Frits van Rhee, Vera P Krymskaya, Dermot Kelleher, Arthur H Rubenstein & David C Fajgenbaum. (2016) Idiopathic multicentric Castleman's disease: a systematic literature review. The Lancet Haematology 3:4, pages e163-e175.
Crossref
Crossref
David C Fajgenbaum & Razelle Kurzrock. (2016) Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease. Immunotherapy 8:1, pages 17-26.
Crossref
Crossref